This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
social-anxiety-disorder
Social Anxiety Disorder
Social anxiety disorder (12% lifetime) involves amygdala hyperreactivity to social threat and striatal dopamine deficit impairing social reward; first-line: SSRIs/SNRIs + CBT with social exposure; β-blockers for performance-only type; MAOIs for severe refractory cases.
Entry Metadata
| Field | Value |
|---|---|
| ID | social-anxiety-disorder |
| Name | Social Anxiety Disorder |
| Status | draft |
| Last reviewed | 2026-06-08 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141-173. · PubMed 2885745
- Stein MB, Stein DJ. Social anxiety disorder. Lancet. 2008;371(9618):1115-1125. · PubMed 18374843
- Goldin PR, Gross JJ. Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion. 2010;10(1):83-91. · PubMed 20141305